cancer

Showing NaN - NaN of 165

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

A Digital Art Activity to Enhance Self-Disclosure and Detection

Recruiting
  • Cancer
  • Digital Art Activity
  • Houston, Texas
    MD Anderson Cancer Center
Nov 7, 2023

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Home Program- A New Paradigm for Acute Care Management of Cancer

Not yet recruiting
  • Cancer
    • Houston, Texas
      MD Anderson Cancer Center
    Jun 14, 2023

    Cannabis and Cannabidiol Among Cancer Patients: A Pilot Study

    Recruiting
    • Cancer
    • Cannabis (Marijuana)
    • Cannabidiol (CBD)
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 20, 2023

    Cancer Trial in Houston (Individual Interview, Meditation Exercise)

    Not yet recruiting
    • Cancer
    • Individual Interview
    • Meditation Exercise
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 28, 2023

    Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +15 more
    • A2B530
    • xT-Onco with HLA-LOH Assay
    • Duarte, California
    • +6 more
    Feb 10, 2023

    Myocarditis Acute, Cancer Trial in Boston (Abatacept plus, Placebo)

    Recruiting
    • Myocarditis Acute
    • Cancer
    • Abatacept plus
    • Placebo
    • Los Angeles, California
    • +16 more
    Feb 1, 2023

    Cancer, NSCLC (NSCLC) Trial in Worldwide (Cofetuzumab Pelidotin)

    Recruiting
    • Cancer
    • Non-small Cell Lung Cancer (NSCLC)
    • Cofetuzumab Pelidotin
    • Birmingham, Alabama
    • +25 more
    Jan 31, 2023

    Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

    Recruiting
    • Tumor
    • +20 more
    • Mobile, Alabama
    • +81 more
    Jan 24, 2023

    Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)

    Recruiting
    • Cancer
    • +4 more
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Jan 24, 2023

    Perceptions of Hospital Care at Home for Cancer: A Qualitative

    Recruiting
    • Cancer
    • Focus Group
    • Interview
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 12, 2023

    Cancer, Solid Tumor, Solid Carcinoma Trial in United States (AMXT1501, DFMO)

    Active, not recruiting
    • Cancer
    • +3 more
    • Austin, Texas
    • +3 more
    Jan 18, 2023

    Cultural Tailoring and Pilot Testing ofInpatient Yoga Therapy

    Not yet recruiting
    • Hematopoietic Stem Cell Transplantation
    • Cancer
    • Yoga Sessions
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 27, 2022

    Cancer Trial in United States (SRK-181, anti-PD-(L)1 antibody therapy)

    Recruiting
    • Cancer
    • SRK-181
    • anti-PD-(L)1 antibody therapy
    • Fullerton, California
    • +13 more
    Jan 6, 2023

    Cancer Trial in Houston (Training, Questionnaire, Interview)

    Active, not recruiting
    • Cancer
    • Training
    • +3 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 16, 2022

    Cancer, Quality of Life, Anxiety Trial in United States (Promoting Resilience in Stress Management (PRISM))

    Recruiting
    • Cancer
    • +6 more
    • Promoting Resilience in Stress Management (PRISM)
    • Los Angeles, California
    • +4 more
    Nov 29, 2022

    Solid Tumors, Cancer Trial in Worldwide (MEDI1191, Durvalumab)

    Active, not recruiting
    • Solid Tumors
    • Cancer
    • MEDI1191
    • Durvalumab
    • La Jolla, California
    • +13 more
    Nov 30, 2022

    NSCLC, Anemia, Cancer Trial in Worldwide (Darbepoetin alfa, Placebo)

    Terminated
    • Non-Small Cell Lung Cancer
    • +3 more
    • Darbepoetin alfa
    • Placebo
    • Anniston, Alabama
    • +566 more
    Nov 4, 2022

    CNS Infections, Pseudotumor Cerebri, Neurological Disorder Trial in Providence, Houston (Device Group 1: Tactile Imaging

    Completed
    • Central Nervous System Infections
    • +6 more
    • Tactile Imaging (VerTouch)
    • Control (palpation)
    • Providence, Rhode Island
    • +1 more
    Nov 23, 2022

    Survivorship, Cancer, Financial Stress Trial in United States (Providing financial navigation via active navigation, ad hoc

    Enrolling by invitation
    • Survivorship
    • +2 more
    • Providing financial navigation via active navigation, ad hoc navigation or no study-based navigation.
    • Los Angeles, California
    • +4 more
    Nov 11, 2022

    Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)

    Completed
    • Advanced Malignancy
    • +5 more
    • AMG 337
    • Los Angeles, California
    • +7 more
    Nov 3, 2022

    Cancer Trial in Houston (IPAD, Augmented Reality)

    Not yet recruiting
    • Cancer
    • IPAD
    • Augmented Reality
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 20, 2022

    Cancer Trial in Saint Louis, Houston (Vopratelimab, Ipilimumab, Nivolumab)

    Active, not recruiting
    • Cancer
    • Saint Louis, Missouri
    • +2 more
    Sep 9, 2022